Related Experiment Video
Updated: Jun 19, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Canadian Cardiovascular Society Clinical Practice Update on Cardiogenetic Testing
Melanie Care1, Laura Arbour2, Liam R Brunham3
1Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Insights
This clinical practice update guides integrating genetic testing for inherited cardiovascular conditions in Canada. It offers strategies to improve early detection, risk stratification, and patient outcomes through enhanced care pathways and provider training.
Area of Science:
- Cardiovascular Medicine
- Medical Genetics
Background:
- Inherited cardiovascular conditions require genetic testing for accurate diagnosis and management.
- Current specialized care models face challenges with increasing demand and limited resources.
- Integrating genetic testing into broader clinical practice is essential for improved patient and family outcomes.
Purpose of the Study:
- To provide guidance on integrating genetic testing for inherited cardiovascular conditions into Canadian clinical practice.
- To outline strategies for enhancing cardiogenetics expertise and literacy among healthcare providers.
- To examine different clinical care models and address implementation challenges.
Main Methods:
- Review of current clinical practice and literature on genetic testing for inherited cardiovascular conditions.
- Analysis of various care delivery models (e.g., genetics clinics, multidisciplinary clinics, mainstreaming, hub-and-spoke).
- Identification of key implementation challenges and development of practical recommendations.
Main Results:
- Foundational steps include establishing expertise networks and clarifying testing indications.
- Various care models present distinct strengths and barriers within the Canadian healthcare context.
- Addressing challenges like variant interpretation, consent, and cascade testing is crucial.
Conclusions:
- Strategic planning, professional training, and equitable resource allocation are vital for managing increased demand.
- Collaborative, interdisciplinary networks are key to successful integration.
- This update supports clinicians and administrators in routine cardiogenetic testing for better outcomes and equity.
Abstract:
This Canadian Cardiovascular Society clinical practice update provides essential guidance on integrating genetic testing into clinical care for inherited cardiovascular conditions, including primary arrhythmias, cardiomyopathies, aortopathies, familial hypercholesterolemia, and congenital heart diseases. Genetic testing for these conditions is crucial for early detection, risk stratification, and management, and significantly influences patient and family outcomes, particularly regarding sudden cardiac death risk. Historically managed within specialized genetics or cardiology clinics, growing demand and limited resources necessitate evolving care pathways for broader integration into general practice. This update outlines foundational steps such as establishing regional cardiogenetic expertise networks, enhancing genetics literacy among providers, and clarifying genetic testing indications and methodologies. It critically examines various clinical care models-traditional medical genetics clinics, multidisciplinary specialty clinics, mainstreaming approaches, and hub-and-spoke models-highlighting their strengths and barriers within the Canadian health care context. Key implementation challenges, including variant interpretation, secondary findings, informed consent complexities, and cascade testing barriers are addressed with practical recommendations for clinicians, genetic counsellors, and health care systems. Furthermore, this document emphasizes strategic planning to effectively manage increasing cardiogenetic testing demands, advocates for increased professional training, equitable resource allocation, national standardization, and policy frameworks. By detailing actionable strategies and promoting collaborative interdisciplinary networks, this update supports clinicians and health care administrators in incorporating cardiogenetic testing into routine cardiovascular care, thereby enhancing clinical outcomes and equity across Canada.
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenomics: Identification of New Drug Targets
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

